Hemophilia A
7 competing products in clinical development for Hemophilia A.
Pipeline by Phase
Phase 37
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Human Coagulation Factor VIII | Chugai Pharmaceutical | Phase 3 | Recruiting | 47 |
| Emicizumab | Chugai Pharmaceutical | Phase 3 | Recruiting | 47 |
| Emicizumab | Chugai Pharmaceutical | Phase 3 | Completed | 40 |
| Emicizumab | Chugai Pharmaceutical | Phase 3 | Completed | 40 |
| Emicizumab + rFVIIa + aPCC | Chugai Pharmaceutical | Phase 3 | Completed | 40 |
| Emicizumab + Factor VIII (FVIII) | Chugai Pharmaceutical | Phase 3 | Completed | 40 |
| Emicizumab | Roche | Phase 3 | Completed | 40 |